EZZ Life Science Holdings Limited

EZZ

AU0000130569

Pharmaceuticals

Market Closed - Australian S.E. Other stock markets 07:10:13 28/06/2024 BST			5-day change	1st Jan Change
1.845 ^AUD	+16.04%		+29.02%	+183.85%

06-27	EZZ Life Science Sees AU$19 Million in Cash by End of Q4	MT
06-25	EZZ Life Science Expanding to US Market After FDA Approval of Food Supplement Products; Shares Hit All-Time High	MT

EZZ Life Science Holdings Limited Declares Fully Franked Final Dividend for the Twelve Month Period Ended 30 June 2023, Payable on 8 December 2023

October 24, 2023 at 05:34 am

EZZ Life Science Holdings Limited announced that after due consideration, the Board has determined the following fully franked final dividend to shareholders for the 12-month period ended 30 June 2023: Dividend amount: $0.01 per share fully franked. Ex-dividend date: 30 October 2023. Record date: 31 October 2023.

Payment date: 8 December 2023.

Latest news about EZZ Life Science Holdings Limited

EZZ Life Science Sees AU$19 Million in Cash by End of Q4	06-27	MT
EZZ Life Science Expanding to US Market After FDA Approval of Food Supplement Products; Shares Hit All-Time High	06-25	MT
EZZ Life Science Signs Five-Year Sales Agreement with Pinehills; Shares Climb 6%	05-31	MT
EZZ Life Science Declares Fully Franked Interim Dividend	05-07	MT
EZZ Life's Receipts from Customers Up 111% in Fiscal Q3	04-25	MT
EZZ Life Science Completes AU$854,000 Placement with Kingstone Venture Capital	04-12	MT
Renewed Rate Cut Hopes Lift Australian Shares	03-27	MT
Ezz Life Science Posts 43% H1 Revenue Increase to AU$21.7 Million, EBITDA Falls 7% to AU$1.7 Million	03-27	MT
EZZ Life Science Holdings Limited Reports Earnings Results for the Half Year Ended December 31, 2023	02-29	CI
EZZ Life Science Holdings Limited Declares Fully Franked Final Dividend for the Twelve Month Period Ended 30 June 2023, Payable on 8 December 2023	24/10/23	CI
EZZ Life Science Holdings Limited Reports Earnings Results for the Full Year Ended June 30, 2023	27/08/23	CI
EZZ Life Science Holdings Limited Announces Dividend of for the Six Months Ended December 31, 2022, Payable on June 23, 2023	15/05/23	CI
Ezz Life Science Declares Interim Dividend; Shares Jump 7%	15/05/23	MT
Ezz Life Science Signs Two-Year Distribution Deal	09/05/23	MT
EZZ Life Science Launches Amazon Online Store in Australia; Shares Up 8%	30/03/23	MT
30,000,000 Ordinary Shares of EZZ Life Science Holdings Limited are subject to a Lock-Up Agreement Ending on 3-MAR-2023.	02/03/23	CI
EZZ Life Science Holdings Limited Reports Earnings Results for the Half Year Ended December 31, 2022	27/02/23	CI
EZZ Life Science Holdings Limited Elects Qizhou Qin as Director	21/11/22	CI
EZZ Life Science Holdings Limited Declares Fully Franked Final Dividend for the Twelve Month Period Ended 30 June 2022, Payable on 16 December 2022	11/10/22	CI
EZZ Life Science Holdings Limited Reports Earnings Results for the Full Year Ended June 30, 2022	31/08/22	CI
Ezz Life Science Launches Overseas Flagship Store on Douyin Platform	09/05/22	MT
Ezz Life Science Holdings Limited Establishes International Store on Douyin	09/05/22	CI
EZZ Life Science Holdings Limited Reports Earnings Results for the Half Year Ended December 31, 2021	28/02/22	CI
EZZ Life Science Holdings Appoints Glenn Cross as Chairperson and Non-Executive Director	30/11/21	CI
EZZ Life Science Holdings Limited Announces Appointments of Directors	30/11/21	CI

Chart EZZ Life Science Holdings Limited

Duration

Period

More charts

Company Profile

EZZ Life Science Holdings Limited is an Australia-based genomic life science company. The Company is engaged in research and development in genomics and precision nutrition with a focus on four human health challenges, including genetic longevity, human papillomavirus (HPV), helicobacter pylori, and weight management. It formulates, produces, markets and distributes health supplements under the brand of EZZ to retailers and consumers domestically and internationally. The Company is also a wholesale distributor of skin care products under the EAORON brand in Australia and New Zealand to pharmacies, supermarkets and specialist retailers. Its products under the EZZ brand include EZZ Hair Growth Spray, EZZ Hair Scrub, EZZ Hair Mask, EZZ Anti-frizz Hair Spray, EZZ Biotic Engastro Capsule, EZZ Coffee Jelly and EZZ Iron Jelly. The EZZ products cover market segments, including vitamin and dietary supplements, sports nutrition, herbal/ traditional and pediatric consumer health products.

Sector

Pharmaceuticals

Calendar

26/08/2024 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
EZZ LIFE SCIENCE HOLDINGS LIMITED	+183.85%	54.67M
ELI LILLY AND COMPANY	+55.32%	815B
JOHNSON & JOHNSON	-6.75%	352B
MERCK & CO., INC.	+13.56%	314B
ABBVIE INC.	+10.68%	303B
ASTRAZENECA PLC	+16.57%	242B
ROCHE HOLDING AG	+2.04%	224B
NOVARTIS AG	+13.31%	218B
AMGEN INC.	+8.48%	168B
PFIZER, INC.	-2.81%	159B

Other Pharmaceuticals